Skip to content

Effect of Motivational Interview as a Strategy in the Reduction of Blood Pressure.

Effect of Motivational Interview as a Strategy in the Reduction of Blood Pressure in Hypertensive Patients in Specialist Clinic- Randomized Clinical Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02892929
Enrollment
120
Registered
2016-09-08
Start date
2016-09-30
Completion date
2019-07-31
Last updated
2021-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Motivational Interviewing, Hypertension, Nursing, Randomized Controlled Trial, Life Style

Brief summary

This randomized clinical trial was designed to test the effectiveness of Motivational Interviewing in lowering blood pressure during six months follow-up.

Detailed description

The lead researcher is a cardiovascular nurse specialist with 10 years of experience in the care of patients with heart disease and she will be responsible for the application of the Motivational Interviewing (MI) technique in the appointments for the intervention group. She also participated in an intensive workshop about MI, which followed the recommendations of the Motivational Interviewing Network of Trainers19 in 2013, and more recently, in 2015 and 2016, she participated in two workshops on advanced MI techniques. During the study there will be monthly supervision with another specialist. The training and the supervision will be the responsibility of a PhD researcher in Psychiatry with consistent experience on Motivational Interviewing and training conducted in the United States with Miller and Rollnick. The sample size was calculated with WinPepi 11.20 software. Sample size was estimated in 100 patients, 50 in the intervention group (IG) and 50 in the control group (CG), considering a difference of 8 mmHg between groups, standard deviation of 14 mmHg, 80% power, and alpha of 0.05. Adding 20% of losses the sample will have 120 patients, 60 for each group. Hypertension outpatients of Hospital de Clínicas de Porto Alegre (HCPA) will be identified by the appointment book and invited to participate in the study through telephone calls. The first appointment will consist in obtaining the ICF and confirmation of eligibility. After ICF's signing and confirmation of eligibility, the patient will be randomized to one of the groups. Participants of both groups will attend monthly appointments: first appointment (D0), appointment of 30, 60, 90, 120, and 150 days, totaling six individual encounters, previously arranged in the Clinical Research Center (CRC) of HCPA, with an average duration of 30 minutes. The randomization list was generated through the website www.randomization.com. The list will be in possession of a professional of the research group, however non-participant of this project. The allocation group of each patient will be hidden by opaque envelopes of identical appearance. The researcher responsible for the application of the MI technique and the one responsible for the conduct of conventional appointments will be blinded to the outcomes of the study; therefore, the application of structured questionnaires, scales, and assessment of other variables of the study will be carried out by a researcher unblinded to the outcomes. Statistical analysis: Continuous variables will be expressed as mean standard deviation or median and interquartile range (25 and 75 percentile). Categorical variables will be expressed in absolute and percentage numbers. Chi-square will be used for associations between sociodemographic and clinical variables with the scores of the Self-Care Scale. The comparison of the quantitative variables between groups will be conducted by the Student's t-test or Mann-Whitney test, according to data's distribution. The values of systolic blood pressure (SBP) and diastolic blood pressure (DBP) during the study, as well as the scores of the Self-Care Scale will be analyzed by the Generalized Estimating Equations (GEE) with Bonferroni correction. The pressure differences between both groups during the treatment will be analyzed by ANOVA test for repeated measurements. Analysis of Covariance will be conducted to adjust possible differences regarding the basal pressure. The 5% level of significance will be adopted and the data will be analyzed in the Statistical Package for the Social Sciences (SPSS) v.20 (Chicago, Illinois, USA).

Interventions

BEHAVIORALMotivational interviewing

The approach combines the principles of patient-centered care with strategies to motivate the change. Since the first appointment, Motivational Interviewing techniques will be used aiming to work the ambivalence that is to seek treatment and modify the unhealthy behavior. From the second encounter until the appointment of 120 days, the participants will be subjected to individual encounters in which the MI approach will be applied focusing on behavior change.

BEHAVIORALPrescriptive Consultation

Prescriptive consultation is the Methodology usual consultation, in which the patient has little room to express themselves and the health professional who determines what and how the patient will hold the care of your health.

Sponsors

Federal University of Health Science of Porto Alegre
CollaboratorOTHER
Hospital de Clinicas de Porto Alegre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Regular monitored in the hypertension outpatient clinic of HCPA for more than six months

Exclusion criteria

* Evident change in cognitive function, such as intellectual disability and dementia.

Design outcomes

Primary

MeasureTime frameDescription
The reduction of at least 8 mmHg in systolic blood pressure and changes in diastolic blood pressure and mean blood pressure.6 monthsMeasured by ABPM-24 h in the first and last protocol appointments

Secondary

MeasureTime frameDescription
improvement of adherence to a low-sodium diet. (Dietary Sodium Restriction Questionnaire - DSRQ)6 monthsScale that measures the adherence to a low-sodium diet.
adherence to self-care behaviors. (Self-care of hypertension Inventory SC-HI)6 monthsThe self-care evaluation was performed using the Self-care of hypertension Inventory (SC-HI), which has proven validity and reliability for this purpose in hypertensive patients. This scale, based on the Middle Range Theory of Self-Care in Chronic Illness, was developed for a group of U.S. investigators and has since been translated and adapted for use in Brazil. The SC-HI measures three dimensions: self-care maintenance, consisting of those behaviors aimed at maintaining and monitoring disease stability; self-care management, i.e., the patient's response to the signs and symptoms of hypertension; and self-care confidence, i.e., self-efficacy in managing the two other domains. The SC-HI has a standardized score between 0-100. Higher score meaning better self-care.
Increase or maintenance of physical activity (International Physical Activity Questionnaire - IPAQ)6 monthsQuestionnaire that mesures the physical activity.
regular use of antihypertensive medications. (Medication assessment questionnaire-MAQ)6 monthsThe study also included the Medication Assessment Questionnaire (MAQ), is a four-item self-report adherence scale developed by Morisky, Green, and Levine to assess medication adherence. This scale is based on the understanding that lack of adherence to drug therapy could occur in one or all of several ways: forgetting, carelessness, discontinuation of medication when feeling better, or initiation of drug use when feeling worse. This scale is scored from 0 to 4, with lower scores reflecting higher adherence.
evaluation of changes in daytime sleepiness. (Epworth Sleepiness Scale)6 monthsScale that measures the changes in daytime sleepiness.
Cessation smoking. (Questionnaire with questions about the amount of cigarettes smoked per week )6 monthsThat will be asked for the patients about the cessation smoking at baseline and at the final evaluation
weight reduction6 monthsWas measured at the baseline and final evaluation.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026